<DOC>
	<DOCNO>NCT01240187</DOCNO>
	<brief_summary>The purpose study investigate bioequivalence 6 x 2 mg tablet one 12 mg tablet perampanel healthy subject .</brief_summary>
	<brief_title>A Study Demonstrate Bioequivalence Between 6 x 2 mg Tablets Perampanel Single 12 mg Tablet Perampanel Healthy Subjects</brief_title>
	<detailed_description>A Single Centre , open label , 2-period , 2-sequence crossover bioequivalence study one group 28 subject .</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<criteria>Healthy male female subject age 1855 year . BMI 1832 kg/m ^2 . Willing able provide write informed consent . Exclusion criterion : Subjects take prescribed counter ( OTC ) medication 2 week prior screen . Subjects special diet dietary aid know modulate drug metabolize enzyme . Subjects take inhibitor CYP450 within 2 week first dose . Subjects receive experimental drug 12 week prior study drug treatment . Subjects history alcohol abuse drink recommend number alcohol unit per week . Subjects consume five caffeinated beverage per day . Subjects smoke 5 cigarette per day . Subjects history drug abuse positive urine drug screen test . Women agree use two method contraception .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>epilepsy</keyword>
</DOC>